Ndinofanira kutanga kuchenesa kenza kuongororwa pa45?

Share This Post

Chidzidzo chitsva chakataurwa paEuropean Digestive Disease Week (UEG) chinoratidza kuti pasinei nenhoroondo yemhuri, colorectal cancer screening yakawedzera kaviri kubva pazera re45 pane 50. (UEG 2017)

Vatsvaguriri vakaratidza kuti huwandu hwevanhu vekolonoscopy kuongorora chirongwa chinokurudzira kuongororwa kwevanhu vanopfuura makore makumi mashanu, asi chiitiko checolorectal cancer pasi pemakore makumi mashanu chawedzera.

Ichi chinotarisirwa kudzidza chakaongorora 6027 kesi dzecolonoscopy. Iwo ekuonekwa kweanowanikwa polyps, adenomas, makuru polyps uye gomarara aive 34.0%, 32.0%, 8.0% uye 3.6%, zvichiteerana. Chimwe chezvakakosha zvakawanikwa zvechidzidzo ichi ndechekuti kana njodzi yeadenoma nekenza kuongororwa ikaongororwa nemazera akasiyana mazera, huwandu hwekuonekwa kwevanhu vari pasi pemakore makumi matatu hwakadzika kwazvo, uye hwakadzikira pamberi pemakore makumi mana nemashanu. Pane kuwedzera kwakakosha.

Ivhareji yekuona polyp chiyero chevarwere 4438 vanopfuura makore makumi mashanu vaive pamusoro pe50%, uye chiyero chekenza chakapfuura 35%. Ivhareji yekuona polyps chiyero chevarwere mazana mashanu nemakumi mashanu nevashanu vane makore makumi mana nemashanu kusvika makumi mana nemapfumbamwe yaive makumi maviri nemasere muzana, uye chiyero chekenza chakabatwa chaive chinenge 5%. Chiyero chekucherechedza chevanhu 515 ≤ makore makumi mana nemana emakore aive akaderera kwazvo. Kunyangwe mushure mekusiya vanhu vane njodzi huru nenhoroondo yemhuri, chiyero chekuonekwa kwepolyps kana gomarara chakange chakakwira pakati pevanhu vane makore makumi mana nemana kusvika makumi mana nemapfumbamwe.

The researchers believe that the research population is a real practice population, so the research conclusions are applicable to the general screening population. 50-year-old should not be used as the starting age for screening, and kenza yakajeka screening should be started from 45-year-old to better prevent colorectal cancer. The results of the study suggest that, even if there is no family history, the risk of disease will increase greatly after the age of 45, which is more critical. 

Subscribe To Newsletter Vedu

Wana zvigadziriso uye usambopotsa blog kubva kuCancerfax

Zvimwe Kuti Uongorore

Kurapa Kwemasero eCAR T kunoitwa nevanhu: Kubudirira Uye Zvinetso
CAR T-Cell kurapa

Kurapa Kwemasero eCAR T: Kubudirira uye Zvinetso

Human-based CAR T-cell therapy inosandura kurapwa kwegomarara nekugadzirisa magene masero emuviri emurwere kuti anange nekuparadza maseru egomarara. Nekushandisa simba rekudzivirira kwemuviri, marapirwo aya anopa marapiro ane simba uye emunhu ane mukana wekuregererwa kwenguva refu mumhando dzakasiyana dzegomarara.

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa
CAR T-Cell kurapa

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa

Cytokine Release Syndrome (CRS) is immune system reaction inowanzo kukonzerwa nemamwe marapirwo senge immunotherapy kana CAR-T cell therapy. Zvinosanganisira kuburitswa kwakanyanya kwemacytokines, zvichikonzera zviratidzo kubva pafivha uye kuneta kusvika kune zvinogona kuuraya hupenyu sekukuvadzwa kwenhengo. Kutungamira kunoda kunyatsotarisisa uye nzira dzekupindira.

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa